Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Arthritis Care & Research|January 3, 2023
Changes in Tophus Composition During Urate-Lowering Therapy: A Dual-Energy Computed Tomography StudyLeanne Chen, Gregory D Gamble, Anne Horne, et al.
Arthritis Research & Therapy|September 16, 2016
Urate crystal deposition and bone erosion in gout: 'inside-out' or 'outside-in'? A dual-energy computed tomography studyPatapong Towiwat, Anthony J Doyle, Gregory D Gamble, et al.
Arthritis Research & Therapy|November 30, 2013
Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal studyAshwin Rajan, Opetaia Aati, Ramanamma Kalluru, et al.
Medical Image Analysis|July 18, 2013
Breast lesion co-localisation between X-ray and MR images using finite element modellingAngela W C Lee, Vijayaraghavan Rajagopal, Thiranja P Babarenda Gamage, et al.
Clinical Rheumatology|April 23, 2018
Predictors of activity limitation in people with gout: a prospective studySarah Stewart, Keith Rome, Alastair Eason, et al.
Seminars in Arthritis and Rheumatism|November 8, 2023
The statistical challenge of analysing changes in dual energy computed tomography (DECT) urate volumes in people with goutSarah Stewart, Greg Gamble, Anthony J Doyle, et al.
Seminars in Arthritis and Rheumatism|October 27, 2021
Denosumab did not improve computerized tomography erosion scores when added to intensive urate-lowering therapy in gout: Results from a pilot randomized controlled trialAngelo L Gaffo, Kenneth Saag, Anthony J Doyle, et al.
Annals of the Rheumatic Diseases|February 26, 2016
Factors associated with change in radiographic damage scores in gout: a prospective observational studyAlastair Eason, Meaghan E House, Zoe Vincent, et al.
Annals of the Rheumatic Diseases|February 1, 2015
Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT studyNicola Dalbeth, Meaghan E House, Opetaia Aati, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Zoledronate for prevention of bone erosion in tophaceous gout: a randomised, double-blind, placebo-controlled trialNicola Dalbeth, Opetaia Aati, Gregory D Gamble, et al.
Pageof 4